Recover act tissue samples and data from various types of cancer for the cancer genome atlas (TCGA) program arra::yes::arra
Ended Awarded Last action
- Contract number
- HHSN261201000034I
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $63,000 obligated
Award facts
- Opportunity
-
- RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $63,000 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 23% used
- $276,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Brigham & Women's Hospital, Inc. for the procurement of tissue samples and associated data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The single-award contract has a ceiling value of $276,000 and a period of performance through March 31, 2015. Under this contract, the NCI issued a $63,000 firm-fixed-price delivery order to Brigham & Women's Hospital for the recovery of tissue samples and data related to the TCGA program. Brigham & Women's Hospital is a major academic medical center and research institution with extensive experience conducting federally-funded biomedical and clinical research across multiple medical specialties. This contract does not contain any small business set-aside designations. The purpose of this IDV is to provide the NCI with access to specialized tissue samples and data to advance its cancer genomics research initiatives under the TCGA program.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Recovery act tissue samples and data from various cancer types for the cancer genome atlas (TCGA) program… | National Cancer Institute (NIH) | $63,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000034I?
HHSN261201000034I was awarded to Brigham & Womens Hospital Inc. by National Cancer Institute (National Institutes of Health) on April 28, 2010.
How much is contract HHSN261201000034I worth?
Orders under HHSN261201000034I have obligated $63,000. HHSN261201000034I's own ceiling is $276,000.
How many orders have been placed under contract HHSN261201000034I?
1 order has been placed under HHSN261201000034I, the latest on May 5, 2010.
Who can order from contract HHSN261201000034I?
HHSN261201000034I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000034I part of a contract vehicle?
Yes. HHSN261201000034I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000034I competed?
The extent of competition for HHSN261201000034I was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV